All tenders
75A50124C00046
LICENSE PATHOGEN REDUCTION TECHNOLOGY (PRT) FOR RED BLOOD CELL (RBC) COMPONENTS TO REDUCE THE RISK OF TRANSFUSION-TRANSMITTED INFECTION (TTI) BY RECOGNIZED, EMERGING, EPIDEMIC, AND ENDEMIC PATHOGENS THAT IS CAPABLE OF TREATING OVER 10 MILLION RBC COM
Office of Assistant Secretary for Preparedness and Response · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedOtherFederal
Basic information
- Reference number
- 75A50124C00046
- Issuing organization
- Office of Assistant Secretary for Preparedness and Response · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- LICENSE PATHOGEN REDUCTION TECHNOLOGY (PRT) FOR RED BLOOD CELL (RBC) COMPONENTS TO REDUCE THE RISK OF TRANSFUSION-TRANSMITTED INFECTION (TTI) BY RECOGNIZED, EMERGING, EPIDEMIC, AND ENDEMIC PATHOGENS THAT IS CAPABLE OF TREATING OVER 10 MILLION RBC COM
- Source
- USASpending (Federal)
- Source ID
- usa-75A50124C00046
Details
- Location
- United States
Description
LICENSE PATHOGEN REDUCTION TECHNOLOGY (PRT) FOR RED BLOOD CELL (RBC) COMPONENTS TO REDUCE THE RISK OF TRANSFUSION-TRANSMITTED INFECTION (TTI) BY RECOGNIZED, EMERGING, EPIDEMIC, AND ENDEMIC PATHOGENS THAT IS CAPABLE OF TREATING OVER 10 MILLION RBC COM Awarded to: CERUS CORPORATION Agency: Department of Health and Human Services Sub-agency: Office of Assistant Secretary for Preparedness and Response Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2024/09/30 12:00:00 AM UTC
- Closing date
- 2031/09/30 12:00:00 AM UTC
Estimated value
$65.4M USD
Classification
Normalized category
Other